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Abstract
Background:  Non-adherence  with  recommended  follow-up  visits  is  a  major  barrier
for  completing  treatment  of  viral  hepatitis  and  is  consequently  associated  with
unfavorable  outcomes  of  health  services.
Objectives:  To  estimate  the  magnitude  and  identify  perceived  reasons  and  patient
characteristics  associated  with  loss  to  follow-up  in  a tertiary  care  setting.
Methods:  A  two-step  cross-sectional  study  design  was  used,  including  a  chart  review
(2011)  followed  by  phone  survey  (2012).  Loss  to  follow-up  was  recorded  among  those
who  were  diagnosed  with  hepatitis  B (HBV)  or  C  (HCV)  during  2009—2010  but  never
ded/scheduled  follow-up  appointment(s).returned  for  recommenPlease  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  Magnitude  and  causes  of  loss  to  follow-up  among
patients  with  viral  hepatitis  at  a  tertiary  care  hospital  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
http://dx.doi.org/10.1016/j.jiph.2016.06.012
Results:  A  total  of  328  patients  (202  HBV  and  126  HCV)  were  included  in  the  current
analysis.  The  average  age  was  49.6  ±  17.9  years,  and  57%  were  males.  Out  of  328,
∗ Corresponding author at: King Saud bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs,
.O. Box 22490, Riyadh 11426, Saudi Arabia. Tel.: +966 504623090; fax: +966 118043045.
E-mail address: balkhyh@ngha.med.sa (H.H. Balkhy).
ttp://dx.doi.org/10.1016/j.jiph.2016.06.012
876-0341/© 2016 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
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131  (40%)  were  not  advised  to  do  follow-up,  and  98  (30%)  were  not  doing  follow-up.
Perceived  reasons  for  loss  to  follow-up  were  as  follows:  unaware  that  a  follow-up
appointment  was  scheduled  (69%),  never  informed  of  need  for  follow-up  by  health-
care  provider  (15%),  personal  belief  that  follow-up  was  not  necessary  (9%),  logistical
reasons  (3%)  and  other  reasons  (5%).  Loss  to  follow-up  was  higher  among  those  who
had  been  diagnosed  with  HBV,  referred  by  non-liver-related  specialty,  never  advised
to  follow-up,  unaware  of  their  diagnosis,  incorrectly  identiﬁed  their  type  of  hepati-
tis,  lacking  hepatitis  complications,  having  full  medical  coverage,  pregnant,  and  those
with  low  knowledge  or  negative  attitude  towards  hepatitis.
ow-up  is  a  signiﬁcant  problem  among  patients  with  hepatitis
 with  several  patient  and  system  failures  being  implicated.
vier  Limited  on  behalf  of  King  Saud  Bin  Abdulaziz  University
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4700 clinic  visits  every  year.
Study designConclusions:  Loss  to  foll
in  a  tertiary  care  center,
©  2016  Published  by  Else
for  Health  Sciences.
Introduction
Viral  hepatitis  is  a  major  global  health  problem
that creates  a  substantial  burden  on  healthcare  ser-
vices [1].  The  World  Health  Organization  (WHO)
estimated that  approximately  two  billion  people
have been  infected  with  hepatitis  B  virus  (HBV),
of whom  over  240  million  are  chronically  infected
[1,2].  Additionally,  approximately  150  million  are
chronically  infected  with  hepatitis  C  virus  (HCV)
[3].  The  complications  arising  from  both  HBV  and
HCV infections  are  responsible  for  over  one  million
deaths every  year  [2,3].
In Saudi  Arabia,  despite  the  considerable  decline
in HBV  and  HCV  infections  following  the  introduc-
tion of  a  universal  HBV  vaccination  strategy  in
1989, universal  blood  bank  screening,  and  premari-
tal screening,  a  recent  study  showed  that  both  HBV
and HCV  incidence  are  higher  than  expected  [4].
Additionally,  HBV-  and  HCV-related  burden  of  liver
disease  is  likely  to  increase  in  the  next  decades
as infected  children  become  older  and  the  large
numbers of  undiagnosed  cases  begin  manifesting
at an  advanced  stage  of  the  disease  [5,6]. This
may further  increase  the  burden  on  healthcare
resources and  translate  to  a  greater  number  of
patients requiring  liver  transplantation  [6].
The efﬁcacy  of  recent  advances  in  hepatitis
screening and  management  in  decreasing  the  bur-
den of  viral  hepatitis  is believed  to  be  undermined
by under-diagnosis,  inefﬁcient  referral  systems,
low patient  awareness,  and  limited  access  to  care
[7,8].  Viral  hepatitis  patients  should  be  followed
for assessing  disease  progression  and  to  monitor  the
response  to  treatment  [9].  It  has  been  shown  that
non-adherence  with  recommended  follow-up  visitsPlease  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  
patients  with  viral  hepatitis  at  a  tertiary  care  hospita
http://dx.doi.org/10.1016/j.jiph.2016.06.012
is a  major  barrier  for  completing  treatment  of  viral
hepatitis  and  is  consequently  associated  with  unfa-
vorable outcomes  of  health  resources  [8,10—12]. In
T
i
fhis  context,  a study  in  Saudi  HCV  patients  showed
hat loss  of  follow-up  was  the  main  reason  for
ailure to  complete  appropriate  treatment  [13].
owever, there  is lack  of  local  data  estimating  the
agnitude  of  the  problem  and  underlying  reasons
ontributing to  it.  More  importantly,  patient  char-
cteristics  associated  with  loss  to  follow-up  have
ever been  examined.  The  objective  of  the  current
tudy  was  to  estimate  the  magnitude  and  iden-
ify perceived  reasons  and  patient  characteristics
ssociated with  loss  to  follow-up  at the  hepatology
utpatient settings  of  a tertiary  care  center  in  Saudi
rabia.
ethods
etting
he  current  study  was  conducted  at  King  Abdu-
aziz Medical  City  (KAMC)  in  Riyadh,  Saudi  Arabia.
AMC (Riyadh)  is  an  approximately  900-bed  tertiary
are facility.  KAMC  provides  healthcare  services
o over  600,000  Saudi  National  Guard  soldiers,
mployees, and  their  families.  The  care  provided
anges from  primary  and  preventive  care  to  tertiary
are. The  public  health  section  of  infection  control
epartment  provides  surveillance,  educational,  and
reventive services,  including  improved  utilization
f preventive  services  for  hepatitis  patients  and
heir contacts.  The  hepatology  division  provides
npatient and  outpatient  services  for  approximatelyMagnitude  and  causes  of  loss  to  follow-up  among
l  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
his  is  a two-step  cross-sectional  study  design,
ncluding chart  reviews  followed  by  phone  survey
or all  those  matching  the  inclusion  criteria  for  this
 INJIPH-611; No. of Pages 9
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agnitude  and  causes  of  loss  to  follow-up  among  pa
tudy.  IRB  approval  was  obtained  from  King  Abdul-
ah International  Medical  Research  Center.
ollow-up process
he  hepatology  clinic  at  KAMC  in  Riyadh  arranges
or follow-up  by  giving  the  patients  3—6  months
sometimes shorter  when  needed)  appointments.
he patient  will  receive  a  printed  slip  indicating  the
xact date  and  time  from  the  appointment  desk  at
he time  of  check  out  from  the  clinic.  However,  the
cheduling  software  cannot  conﬁrm  the  exact  date
f it  is  longer  than  90  days.  Therefore,  the  patient
ill be  placed  on  a  waiting  list  for  that  day  until
t is  less  than  90  days,  when  the  appointment  is
hen conﬁrmed  by  calling  and/or  sending  an  SMS
o the  patient’s  mobile.  As  per  the  policy  of  the
ospital, if  a  patient  does  not  show  on  three  con-
ecutive  times,  he/she  will  require  a  new  referral
nd will  be  considered  ‘‘never  returned’’.  Loss  to
ollow-up  for  the  purpose  of  this  study  was  deﬁned
s those  who  were  diagnosed  with  viral  hepatitis
ut never  returned  for  recommended/scheduled
ollow-up appointment(s),  as  documented  in  the
atient  chart.
hart review
etween  July  and  October  2011,  we  retrospectively
eviewed the  charts  of  the  patients  attending  the
epatology  clinic  at  KAMC  in  Riyadh.  Data  were
bstracted  for  those  who  were  diagnosed  with  hep-
titis B or  C  between  January  2009  and  December
010 and  were  eligible  to  receive  additional  health-
are services  at  KAMC.  The  following  variables  were
bstracted  from  the  patient  charts:  demographics,
ligibility for  medical  coverage,  the  type  and  date
f hepatitis  diagnosis,  referring  specialty,  the  status
f follow-up,  hepatitis  complications,  comorbidity,
nd death.  No  consent  forms  were  collected  as  the
tudy was  considered  a  routine  retrospective  eval-
ation activity.
hone survey
atients  who  were  alive  and  eligible  for  enroll-
ent as  per  the  chart  review  were  further
ubjected  to  a  phone  survey  between  January  and
ecember  2012.  Consent  was  obtained  from  the
atient  or  his/her  guardians  over  the  phone  after
xplaining  the  objectives  of  the  study.  An  approx-
mately  20-min  questionnaire  was  conducted  withPlease  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  
patients  with  viral  hepatitis  at  a  tertiary  care  hospita
http://dx.doi.org/10.1016/j.jiph.2016.06.012
hose who  gave  consent.  The  following  questions
ere asked/conﬁrmed:  age,  gender,  marital  status,
ccupation,  family  income,  awareness  of  hepati-
is diagnosis  and  types,  eligibility  for  healthcare
4
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ts  with  viral  hepatitis  3
ervices,  status  of  hepatitis  follow-up  including
easons for  missed  follow-up,  knowledge  of  hep-
titis disease,  attitude  towards  hepatitis  and  its
ollow-up.  Those  who  did  not  answer  the  phone  ﬁve
ifferent  times,  including  those  who  did  not  update
heir contacts,  were  labeled  as  could  not  reach.
ligibility
atients  who  were  diagnosed  with  hepatitis  B
nd/or C during  2009—2010,  who  were  eligible  to
eceive medical  and  follow-up  care  at  one  of  the
ospitals  of  National  Guard  Health  Affairs  (NGHA)
ncluding  KAMC  in  Riyadh,  and  able  to  give  a  ver-
al consent  to  complete  the  phone  survey  were
ncluded in  the  study.  Those  who  died  before  the
hone  survey,  or  with  lack  of  laboratory  conﬁrma-
ion of hepatitis,  or  did  not  complete  the  phone
urvey due  to  refusal  or  inability  to  contact,  were
xcluded  from  the  study.
tatistical analyses
ata  were  presented  as  frequencies  and  percent-
ges for  categorical  data  and  mean  and  standard
eviation (SD)  or  median  and  inter-quartile  range
IQR) for  continuous  data.  Demographic  and  clini-
al characteristics  as  well  as  patient  knowledge  and
wareness for  hepatitis  were  compared  between
hose who  did  and  those  who  did  not  follow-
p their  disease.  Signiﬁcant  differences  between
roups were  examined  using  the  Chi-square  test  or
isher’s exact  test  (as  appropriate)  for  categorical
ata and  Student’s  t-test  for  continuous  data.  All
-values were  two-tailed,  and  a  p-value  <0.05  was
onsidered  signiﬁcant.  SPSS  software  (release  21.0,
PSS Inc.,  Chicago,  U.S.)  was  used  for  all  statistical
nalyses.
esults
ut  of  the  initial  list  created  by  chart  review,  phone
alls indicated  that  131  were  not  eligible  to  com-
lete the  phone  survey  because  of  death  (N  =  98),
ack of  eligibility  to  receive  medical  and  follow-up
are at  one  of  the  NGHA  hospitals  (N  =  25),  or  hep-
titis diagnosis  was  conﬁrmed  before  2009  (N  =  8).
dditionally,  295  did  not  complete  the  phone  survey
ue to  refusal  (N  =  33)  or  inability  to  reach  (N  =  262).
 total  328  patients  completed  the  phone  survey
nd were  included  in  the  current  analysis.Magnitude  and  causes  of  loss  to  follow-up  among
l  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
As shown  in  Table  1, the  average  age  was
9.6 ±  17.9  years  and  the  majority  of  patients  were
ales (57%)  and  married  (80%).  Approximately  half
49%) of  the  patients  were  non-educated  or  had  only
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Table  1  Demographic  and  clinical  characteristics  of  the  study  patients  by  the  follow-up  status.
No  follow-up
N =  98
Follow-up
N  =  230
Total
N  =  328
p-Value
Age,  Mean  ±  SD  50.3  ±  18.9  49.3  ±  17.5  49.6  ±  17.9  0.635
Age  groups
<30  16  (16.3%)  34  (14.8%)  50  (15.2%)  0.112
30—44  31  (31.6%)  64  (27.8%)  95  (29.0%)
45—64  22  (22.4%)  82  (35.7%)  104  (31.7%)
≥65  29  (29.6%)  50  (21.7%)  79  (24.1%)
Gender
Female  42  (42.9%) 99  (43.0%) 141  (43.0%) 0.975
Male  56  (57.1%) 131  (57.0%) 187  (57.0%)
Marital  status
Not-married  23  (23.5%)  43  (18.7%)  66  (20.1%)  0.324
Married  75  (76.5%)  187  (81.3%)  262  (79.9%)
Educational  level
Non-educated/primary  49  (50.0%)  112  (48.7%)  161  (49.1%)  0.895
Secondary  or  technical  education  35  (35.7%)  88  (38.3%)  123  (37.5%)
University  14  (14.3%)  30  (13.0%)  44  (13.4%)
Monthly  household  income
<5,000  29  (30.2%)  63  (28.6%)  92  (29.1%)  0.481
5,000—9,999  42  (43.8%)  85  (38.6%)  127  (40.2%)
≥10,000  25  (26.0%)  72  (32.7%)  97  (30.7%)
Current  employment  status
Employed  32  (32.7%)  82  (35.8%)  114  (34.9%)  0.708
Unemployed  51  (52.0%)  119  (52.0%)  170  (52.0%)
Retired  15  (15.3%)  28  (12.2%)  43  (13.1%)
Medical  care  coverage
Full  coverage  89  (93.7%)  193  (84.3%)  282  (87.0%)  0.022
Limited  coverage 6  (6.3%)  36  (15.7%)  42  (13.0%)
Comorbidity
None  58  (59.2%)  135  (58.7%)  193  (58.8%)  0.840
Single  18  (18.4%) 48  (20.9%)  66  (20.1%)
Multiple  22  (22.4%)  47  (20.4%)  69  (21.0%)
Types  of  comorbidity
Hypertension  30  (30.6%) 57  (24.8%) 87  (26.5%)  0.274
Diabetes  20  (20.4%) 61  (26.5%) 81  (24.7%) 0.240
Renal  disease 9  (9.2%) 18  (7.8%) 27  (8.2%)  0.682
Heart  disease  2  (2.0%)  3  (1.3%)  5  (1.5%)  0.637
Cancer  0  (0.0%)  5  (2.2%)  5  (1.5%)  0.327
Others  4  (4.1%)  10  (4.3%)  14  (4.3%)  1.000
8
s
h
s
w
c
s
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tPregnancy  during  2009—2010  12  (30.0%)  
Family  history  of  hepatitis  24  (24.5%)  
primary  education.  Approximately  40%  had  house-
hold income  between  SR  5,000  and  9,000,  with
the rest  approximately  divided  equally  between
SR <5,000  and  ≥10,000.  Approximately  one-third
(35%) were  employed,  while  the  rest  were  either
unemployed (52%)  or  retired  (13%).  The  majority
(87%) had  full  NGHA  medical  coverage.  More  than
40% of  the  patients  had  one  or  more  comorbid-
ity, with  hypertension  (27%)  and  diabetes  (25%)
being the  most  common.  Close  to  20%  of  femalePlease  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  
patients  with  viral  hepatitis  at  a  tertiary  care  hospita
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patients were  pregnant  and  30%  of  the  patients
had a  family  member  diagnosed  with  hepatitis.  As
shown in  Table  2, 62%  of  the  patients  had  conﬁrmed
hepatitis B  and  38%  had  conﬁrmed  hepatitis  C.  Only
d
t
(
i14  (14.6%)  26  (19.1%)  0.037
75  (32.6%)  99  (30.2%)  0.120
%  of  the  patients  were  referred  from  liver-related
pecialties. Approximately  19%  had  one  or  more
epatitis  complication/comorbidity,  mainly  cirrho-
is and  fatty  liver.  The  majority  (87%)  of  the  patients
as aware  of  having  viral  hepatitis,  and  of  them  90%
orrectly identiﬁed  the  type  of  virus.
Out  of  328  patients  who  completed  the  phone
urvey, 131  (40%)  were  not  advised  to  do  follow-up
nd 98  (30%)  were  not  doing  follow-up  for  hepati-
is (Table  3).  The  median  number  of  follow-up  visitsMagnitude  and  causes  of  loss  to  follow-up  among
l  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
one since  diagnosis  was  4  (IQR;  2—10)  done  inside
he NGHA  facilities  (58%),  outside  NGHA  facilities
13%), or  in  both  inside  and  outside  NGHA  facil-
ties (29%).  Out  of  the  98  who  did  not  follow-up
ARTICLE IN PRESSJIPH-611; No. of Pages 9
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Table  2  Awareness  of  hepatitis  diagnosis  among  the  study  patients  by  the  follow-up  status.
No  follow-up
N =  98
Follow-up
N =  230
Total
N =  328
p-Value
Chart  hepatitis  type
Hepatitis  B  70  (71.4%)  132  (57.4%)  202  (61.6%)  0.017
Hepatitis  C  28  (28.6%)  98  (42.6%)  126  (38.4%)
Chart  referring  department
Hepatol-
ogy/hepatobiliary/gastroenterology/liver
transplant
1 (1.0%)  26  (11.4%)  27  (8.3%)  0.001
Infectious  disease/Infection  control 3  (3.1%) 11  (4.8%) 14  (4.3%)
Primary  care/family  medicine 21  (21.4%) 62  (27.1%) 83  (25.4%)
Other  specialties  37  (37.8%)  52  (22.7%)  89  (27.2%)
Unknown  specialty  36  (36.7%)  78  (34.1%)  114  (34.9%)
Hepatitis  complications/comorbidity
None  94  (95.9%)  172  (74.8%)  266  (81.1%)  <0.001
Single  4  (4.1%)  33  (14.3%)  37  (11.3%)
Multiple  0  (0.0%)  25  (10.9%)  25  (7.6%)
Types  of  hepatitis  complications/comorbidity
Chronicity  0  (0.0%)  1  (0.4%)  1  (0.3%)  1.000
Fatty  liver  0  (0.0%)  20  (8.7%)  20  (6.1%)  0.003
Cirrhosis  1  (1.0%)  36  (15.7%)  37  (11.3%)  <0.001
Carcinoma  or  metastasis  0  (0.0%)  6  (2.6%)  6  (1.8%)  0.184
Signs  of  liver  cell  failure  1  (1.0%)  11  (4.8%)  12  (3.7%)  0.117
Liver  transplant 0  (0.0%)  4  (1.7%)  4  (1.2%)  0.321
Others  2  (2.0%)  8  (3.5%)  10  (3.0%)  0.729
Patient’s  awareness  of  having  hepatitis
No  40  (40.8%) 2  (0.9%)  42  (12.8%)  <0.001
Yes 58  (59.2%)  228  (99.1%)  286  (87.2%)
Patient’s  identiﬁcation  of  correct  type  of
Hepatitis
No  3  (3.1%) 9  (3.9%) 12  (3.7%)  <0.001
Yes 47  (48.0%) 211  (92.1%) 258  (78.9%)
Do  not  know  48  (49.0%)  9  (3.9%)  57  (17.4%)
Heard  of  Hepatitis  before  being  diagnosed
No  47  (48.0%)  91  (39.6%)  138  (42.1%)  0.159
Yes  51  (52.0%)  139  (60.4%)  190  (57.9%)
Have  been  advised  to  follow-up
(82.5
(17.5
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Yes  17  
or  hepatitis,  68%  provided  a  reason  for  lack  of
ollow-up, which  included  the  following:  unaware
hat follow-up  appointment  was  scheduled  (69%),
ever informed  of  need  for  follow-up  by  healthcare
rovider (15%),  and  personal  belief  that  follow-up
as not  necessary  (9%),  in  addition  to  logistic  (3%)
nd other  (5%)  reasons.
Patients’  knowledge  and  attitude  toward  hepati-
is disease  are  shown  in  Table  4. Less  than  half  of
he patients  were  aware  that  hepatitis  is  a  chronic
isease  (44%)  and  can  cause  cancer  (34%).  Approx-
mately  half  (52%)  of  the  patients  were  aware  thatPlease  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  
patients  with  viral  hepatitis  at  a  tertiary  care  hospita
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epatitis  can  cause  cirrhosis  and  approximately
wo-thirds  (67%)  were  aware  that  the  disease  could
e managed  and  controlled  with  medicine.  Approx-
mately  half  of  the  patients  did  not  feel  stigmatized
l
t
n
o%)  51  (22.3%)  131  (40.2%)  <0.001
%)  178  (77.7%)  195  (59.8%)
y  being  viral  hepatitis  carriers  (51%)  but  worried
bout  their  health  (51%).  The  majority  (66%)  felt
hey had  tolerant  families,  but  41%  had  the  impres-
ion that  hepatitis  patients  have  a more  difﬁcult
ime getting  married.  The  majority  believed  that
egular follow-up  is  beneﬁcial  to  their  health  (84%),
oes not  represent  a ﬁnancial  burden  (75%),  and  is
onvenient  (52%).
As  shown  in  Tables  1  and  2, loss  to  follow-up  was
igher  among  those  who  had  been  diagnosed  with
epatitis  B  compared  with  hepatitis  C (p  = 0.017),
eferred  by  other  specialties  compared  with  aMagnitude  and  causes  of  loss  to  follow-up  among
l  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
iver-related  specialty  (p  =  0.008),  never  advised
o follow-up  (p  <  0.001),  unaware  of  their  diag-
osis (p  < 0.001),  incorrectly  identiﬁed  their  type
f hepatitis  (p  <  0.001),  lacking  other  additional
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Table  3  Hepatitis  follow-up  among  the  study
patients.
Characteristics  N  (%)
Have  been  advised  to  follow-upa
No  131  (40.2%)
Yes  195  (59.8%)
Follow-up  done
No 98  (29.9%)
Yes 230  (70.1%)
Location  of  follow-up
Inside  NGHA 134  (58.3%)
Outside  NGHA 29  (12.6%)
Both  67  (29.1%)
Number  of  follow-up  visits  done
Mean  ±  SD  2.8  ±  11.0
Median  &  IQR  4  (2—10)
Reason  was  provided  for  missed
follow-up
No  31  (31.6%)
Yes  67  (68.4%)
Reasons  for  missed  follow-up
I do  not  know  about  follow-up  46  (68.7%)
No  advice  was  given  for  follow-up  10  (14.9%)
I  do  not  think  follow-up  is  necessary  6  (9.0%)
I  could  not  get  to  hospital 2  (3.0%)
I  am  worried  about  what  people
might  think
1 (1.5%)
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cOther  reasons 3(4.5%)
a Two missing data
liver  damage/pathology  compared  with  patients
who have  other  pathology/damage  (p  <  0.001),
having comprehensive  compared  with  limited  med-
ical coverage  (p  =  0.022%),  and  pregnant  patients
(p = 0.037).  As  shown  in  Table  4, the  loss  to
follow-up was  higher  among  those  who  had  lack
of knowledge  (wrong  and  no  knowledge  com-
bined) about  the  association  with  liver  cirrhosis
(p = 0.029)  or  the  possibility  of  hepatitis  manage-
ment (p  =  0.032)  compared  with  those  who  had  such
knowledge.  Similarly,  the  loss  to  follow-up  was
higher  among  those  who  had  a  negative  attitude
toward several  items  of  hepatitis  lifestyle  and  man-
agement.  For  example,  compared  with  those  who
had the  opposite  attitude,  loss  to  follow-up  was
higher among  those  who  did  not  believe  (negative
and no  attitude  combined)  that  regular  follow-up  is
beneﬁcial for  their  health  or  believed  it  represents
a ﬁnancial  burden  (p  <  0.001  for  each).
DiscussionPlease  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  
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We  are  reporting  30%  loss  to  follow-up  among
patients with  HBV  or  HCV  at  our  tertiary  care  cen-
ter, whether  from  the  primary  healthcare  clinics  or
r
w
n
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he  hepatology  clinic  in  Saudi  Arabia.  This  rate  may
e considered  substantial  considering  the  free  pri-
ary and  tertiary  care  services  that  our  patients
re entitled  to.  For  example,  1-  and  3-year  loss
f follow-up  at  a  gastroenterology  outpatient  clinic
n Japan  were  estimated  at  7—12%  among  patients
ith HBV  and  HCV  who  underwent  liver  biopsy
uring baseline  hospitalization  [14]. Additionally,
pproximately 9%  of  patients  who  started  treat-
ent for  HCV  at  a  tertiary  care  hospital  in  Saudi
rabia failed  to  complete  their  treatment  course
ecause  of  loss  to  follow-up  [13]. However,  this  loss
o follow-up  represented  more  than  70%  of  all  those
ho did  not  complete  their  treatment  course  [13].
It has  been  demonstrated  that  hepatitis  patients
ho are  referred  by  a  gastroenterology  specialist
ave a high  likelihood  of  adherence  to  hepatitis
anagement [15].  As  the  current  study  was  done  at
 tertiary  care  center  which  is considered  a referral
ite, the  reported  30%  may  underestimate  the  mag-
itude of  the  problem  at  primary  care  centers  and
t the  community  level,  where  many  people  have
ever been  diagnosed  or  referred.  For  example,  it
as been  estimated  that  only  20—30%  of  patients
ith HBV  in  the  US  are  actually  aware  of  their  HBV
tatus [16].  Additionally,  referral  rates  of  patients
ith HCV  seen  at  primary  care  centers  in  the  US
ange from  40%  among  a largely  minority  patient
opulation [17]  to  77%  in  a largely  white  patient
opulation [18].  As  several  studies  indicated  that
oss of  follow-up  or  premature  withdrawal  were
mong  the  most  frequent  reasons  for  deferring
reatment in  patients  with  HBV  and  HCV  [11,12,19],
he current  ﬁndings  may  indicate  a  considerable
umber of  treatment  failures  that  demand  imme-
iate steps  to  reduce  the  rate  of  loss  to  follow-up.
The main  reason  for  loss  to  follow-up  as
erceived by  the  patients  in  the  current  study
as the  unawareness  that  follow-up  appointment
as scheduled.  Logistic  reasons,  on  the  other
and, were  much  less  frequent  and  the  majority
f the  patients  did  not  consider  follow-up  as  a
nancial  burden.  Previous  similar  studies  showed
hat both  lack  of  knowledge/awareness  and  logis-
ic/ﬁnancial  reasons  are  important  perceived  barri-
rs [10,19,20]. For  example,  self-perceived  barriers
o care  access  in  patients  with  chronic  HCV  recently
eferred  to  hepatology  clinics  in  the  US  included
ack of  ﬁnancial  resources,  lack  of  knowledge,  lack
f competent  specialized  professionals,  stigmati-
ation  by  the  community,  and  long  distances  to
linics offering  care  [19]. Additionally,  the  bar-Magnitude  and  causes  of  loss  to  follow-up  among
l  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
iers reported  among  Chinese—Canadian  patients
ith chronic  HBV  included  lack  of  time,  inconve-
ience, language  barriers,  and  long  travel  distance,
ith  inadequate  patient  awareness  associated  with
Please  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  Magnitude  and  causes  of  loss  to  follow-up  among
patients  with  viral  hepatitis  at  a  tertiary  care  hospital  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
http://dx.doi.org/10.1016/j.jiph.2016.06.012
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Table  4  Knowledge  and  attitude  towards  hepatitis  disease  among  the  study  patients  by  the  follow-up  status.
No  follow-up
N =  98
Follow-up
N =  230
Total
N =  328
p-Value
Knowledge
Hepatitis  can  be  a  chronic  disease
False  6  (6.1%)  23  (10.0%)  29  (8.8%)  0.237
True  39  (39.8%)  104  (45.2%)  143  (43.6%)
I  don’t  know  53  (54.1%)  103  (44.8%)  156  (47.6%)
Hepatitis  can  cause  liver  cancer
False  5  (5.1%) 24  (10.4%) 29  (8.8%) 0.275
True 33  (33.7%) 78  (33.9%) 111  (33.8%)
I  don’t  know 60  (61.2%) 128  (55.7%) 188  (57.3%)
Hepatitis  can  cause  liver  cirrhosis
False  1  (1.0%)  9  (3.9%)  10  (3.0%)  0.029
True  43  (43.9%)  128  (55.7%)  171  (52.1%)
I  don’t  know  54  (55.1%)  93  (40.4%)  147  (44.8%)
Hepatitis  can  be  managed  and  controlled
with  medicine
False  10  (10.2%)  23  (10.0%)  33  (10.1%)  0.032
True  57  (58.2%)  164  (71.3%)  221  (67.4%)
I  don’t  know  31  (31.6%)  43  (18.7%)  74  (22.6%)
Attitude
I  feel  guilty  about  being  a  Hepatitis
patient
Disagree/strongly  disagree 34  (34.7%) 132  (57.9%) 166  (50.9%)  <0.001
Neutral  51  (52.0%) 46  (20.2%)  97  (29.8%)
Agree/strongly  agree 13  (13.3%) 50  (21.9%) 63  (19.3%)
I  feel  worried  about  my  health  because  I
have  Hepatitis
Disagree/strongly  disagree  20  (20.4%)  68  (29.7%)  88  (26.9%)  <0.001
Neutral  44  (44.9%)  30  (13.1%)  74  (22.6%)
Agree/strongly  agree  34  (34.7%)  131  (57.2%)  165  (50.5%)
My  family  and  friends  are  not  tolerant  of
me  being  a  Hepatitis  patient
Disagree/strongly  disagree  41  (41.8%)  176  (76.9%)  217  (66.4%)  <0.001
Neutral  50  (51.0%)  36  (15.7%)  86  (26.3%)
Agree/strongly  agree  7  (7.1%)  17  (7.4%)  24  (7.3%)
Hepatitis  patients  have  a  harder  time
getting  married
Disagree/strongly  disagree  22  (22.4%)  60  (26.1%)  82  (25.0%)  0.219
Neutral  40  (40.8%)  71  (30.9%)  111  (33.8%)
Agree/strongly  agree  36  (36.7%)  99  (43.0%)  135  (41.2%)
Regular  follow-ups  are  beneﬁcial  to  my
health
Disagree/strongly  disagree  4  (4.1%)  9  (3.9%)  13  (4.0%)  <0.001
Neutral  30  (30.6%)  11  (4.8%)  41  (12.5%)
Agree/strongly  agree  64  (65.3%)  210  (91.3%)  274  (83.5%)
It  is  a  heavy  ﬁnancial  burden  for  me  to
continue  regular  follow-ups
Disagree/strongly  disagree  67  (68.4%)  178  (77.4%)  245  (74.7%)  <0.001
Neutral  20  (20.4%)  10  (4.3%)  30  (9.1%)
Agree/strongly  agree  11  (11.2%)  42  (18.3%)  53  (16.2%)
It  is  inconvenient  for  me  to  continue
regular  follow-ups
Disagree/strongly  disagree  51  (52.0%)  119  (51.7%)  170  (51.8%)  0.071
Neutral  31  (31.6%)  51  (22.2%)  82  (25.0%)
Agree/strongly  agree  16  (16.3%)  60  (26.1%)  76  (23.2%)
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lower  rate  of  follow-up  at  a  tertiary  care  center
[20].  From  the  primary  care  physician  perspective,
poor compliance  of  patients  with  HBV  is  caused  by
inadequate  awareness  of  the  disease  or  treatment
beneﬁt, state  of  denial,  fear  of  stigmatization  in
society, costs  and  discomfort  of  investigations,  and
lack of  recall/reminder  system  [21].  The  variabil-
ity of  the  reasons  in  the  current  and  above  studies
may reﬂect  the  lower  education  level  (awareness)
and higher  unemployment  (time)  of  our  patients,  in
addition to  the  free  care  provided  (cost).
Inadequate  patient  awareness  and  lack  of  follow-
up advice  were  consistently  associated  with  loss
to follow-up  in  the  current  and  previous  studies
[20,22].  The  current  ﬁnding  may  reﬂect  the  inad-
equate education  received  by  our  patients  at  the
hepatology  clinic,  which  was  only  done  during  the
clinic visit.  The  lack  of  follow-up  advice  is  probably
explained by  misunderstanding  of  the  physician  rec-
ommendation,  missing  calls  or  SMS  conﬁrming  the
date and  time  of  follow  up  appointments,  or  fail-
ure of  the  staff  to  conﬁrm  the  appointments  with
the patient.  It  was  shown  that  more  involvement
of public  health  services  can  increase  the  number
of patients  with  HBV  seen  by  a  specialist  by  almost
20% [22]. Public  health  nurses  in  our  facility  were
working  on  improving  hepatitis  knowledge  among
hepatitis  patients  and  their  families  and  acted  as
a linkage  of  infected  persons  with  care  services.
This was  done  by  phone  and  in  weekly  public  health
clinic,  where  patients  can  receive  education  and
referrals  while  family  members  can  receive  educa-
tion and  immunization.
Unlike previous  studies  [14], loss  to  follow-up
in the  current  study  was  higher  with  HBV  than
HCV. This  may  be  explained  by  the  fact  that  non-
complicated  hepatitis  that  was  linked  to  loss  to
follow-up  in  our  study  (Table  2) was  more  preva-
lent in  HBV  compared  with  HCV  (data  are  not
shown). Additionally,  loss  to  follow-up  in  the  cur-
rent study  was  higher  with  full  medical  coverage.
This conﬂicting  ﬁnding  was  not  unexpected  in  our
facility.  Both  full  and  limited  coverage  were  enti-
tled free  follow-up,  the  difference  was  that  limited
follow-up  was  granted  for  a  group  of  non-eligible
patients with  certain  comorbidities,  including  hep-
atitis. Those  patients  were  probably  keen  to  use
the advantage.  Finally,  the  higher  loss  to  follow-
up among  patients  referred  from  non-liver-related
specialties  may  indicate  the  need  for  involv-
ing and  educating  healthcare  providers  in  these
specialties.Please  cite  this  article  in  press  as:  Balkhy  HH,  et  al.  
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Interestingly,  our  patients  were  probably  differ-
ent from  typical  patients  with  hepatitis  in  the  West.
In Western  studies,  where  the  prevalence  of  hep-
atitis is very  low  and  highly  linked  to  intravenous
F
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rug  use  (IDU)  [23], studying  the  patient  charac-
eristics for  non-referral  or  loss  to  follow-up  have
ften focused  on  these  groups,  with  depression  a
ajor mediator  or  risk  factor  [24].  For  example,
epatitis patients  who  were  lost  to  follow-up  and
efused treatment  were  more  likely  to  have  current
lcohol  and  drug  use  [11,15].  Similarly,  psychiatric
omorbidity was  identiﬁed  as  a  major  cause  of  lack
f hepatitis  treatment  [15,19].  On  the  other  hand,
epatitis  in  Saudi  Arabia,  especially  in  the  National
uard  population,  is  more  prevalent  and  less  likely
o be  associated  with  drug/alcohol  abuse  [25].  How-
ver, we  did  not  collect  data  in  the  current  study
bout  the  substance  abuse  or  depression  to  com-
are.
As previous  studies  largely  focused  on  referral
arriers, we  believe  that  the  current  study,  that
ocused  on  the  risk  of  loss  to  follow-up  after  refer-
al, represents  a valuable  addition,  both  locally  and
nternationally.  The  study  covered  several  potential
atient  and  system  failures  in  a  very  busy  hep-
tology clinic.  Additionally,  the  design  used  both
harts and  phone  calls  to  abstract/conﬁrm  infor-
ation.  Nevertheless,  we  acknowledge  a number
f limitations.  Being  a  single  center  study,  the  ﬁnd-
ngs should  be  cautiously  generalized  to  similar
ettings. The  design  being  cross-sectional  cannot
onﬁrm  causal  relationship.  Additionally,  the  num-
er of  patients  who  could  not  be  reached  was
onsiderable. Finally,  some  useful  data  for  inter-
ational  comparisons  were  missing  such  as  IDU  and
epression.  However,  none  of  these  limitations  are
onsidered a signiﬁcant  threat  to  the  validity  of  the
tudy ﬁndings.
In conclusion,  loss  to  follow-up  is  a  signiﬁcant
roblem among  patients  with  viral  hepatitis  receiv-
ng care  in  our  tertiary  care  center.  Several  patient
nd system  failures  have  been  identiﬁed.  The
ndings  may  indicate  the  need  for  more  focused
atient education  and  more  efﬁcient/ﬂexible  refer-
al, scheduling,  and  rescheduling  system.  This  may
e achieved  through  establishing  a dedicated  public
ealth center  that  is  concerned  with  patient  edu-
ation and  follow-up.  Such  a  center  will  need  to  be
inked to  specialty  clinics  and  trained  public  health
ersonal  to  provide  the  proper  advice  [22,23,26].
inally, new  methods  for  patient  reminder  and
ollow-up needs  to  be  investigated  in  our  society,
uch as  customized  text  message  reminders,  emails
nd others  means  of  notiﬁcation  [21].Magnitude  and  causes  of  loss  to  follow-up  among
l  in  Saudi  Arabia.  J  Infect  Public  Health  (2016),
unding
o  funding  sources.
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